Enrique R. Arzac - 21 Apr 2022 Form 4 Insider Report for ADAMS DIVERSIFIED EQUITY FUND, INC. (ADX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
26 Apr 2022, 10:56:45 UTC
Prior SEC filing
09 Feb 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Gail L. Valenti as Attorney-in-Fact for Enrique R. Arzac

Key filing fact

Enrique R. Arzac filed Form 4 for ADAMS DIVERSIFIED EQUITY FUND, INC. (ADX) on 26 Apr 2022.

Key facts

  • This page summarizes Enrique R. Arzac's Form 4 filing for ADAMS DIVERSIFIED EQUITY FUND, INC. (ADX).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 26 Apr 2022, 10:56.

Change

  • Previous filing in this sequence was filed on 09 Feb 2022.
  • Current net transaction value: +$22,062.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ADX transaction

Common Stock

Award

Transaction value
$0
Shares
+72
Change %
+0.35%
Price
$0.000000
Shares after
20,831
Date
21 Apr 2022
Ownership
Direct
Footnotes
F1, F2
ADX transaction

Common Stock

Other

Transaction value
$0
Shares
+0
Change %
+0.23%
Price
$0.000000
Shares after
0
Date
21 Apr 2022
Ownership
By Trust
Footnotes
F3, F4
ADX transaction

Common Stock

Award

Transaction value
$22,062
Shares
+1,225
Change %
+13%
Price
$18.01
Shares after
10,575
Date
21 Apr 2022
Ownership
By Trust
Footnotes
F2, F4, F5, F6
ADX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
29,319
Date
21 Apr 2022
Ownership
By Trust
Footnotes
F2, F4
ADX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
9,658
Date
21 Apr 2022
Ownership
Indirect/Other
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Enrique R. Arzac is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 6 footnotes

Footnote F1

These shares accrued as dividend equivalents on deferred stock units (shares received in lieu of director retainer fees). The Issuer's stock traded in a range of $16.77 - $19.61 during 2022.

Footnote F2

Dr. Arzac's cumulative beneficial ownership reflects the exempt transactions reported herein and also certain changes in direct and indirect ownership balances resulting from transfers among accounts.

Footnote F3

This fractional share was acquired in exempt transactions as a result of dividend reinvestment. The Issuer's stock traded in a range of $16.77 - $19.61 during 2022.

Footnote F4

By the Enrique R. Arzac TTEE The Enrique R. Arzac TR UA DTD 12/28/2012 Trust.

Footnote F5

Of these shares, 695 shares accrued as dividend equivalents on 750 restricted stock units, which were granted in 2007 and deferred until retirement on 04/21/2022. Another 530 shares accrued as dividend equivalents on 750 restricted stock units, which were granted in 2013 and deferred until retirement on 04/21/2022. The Issuer's stock average trading price on 04/21/2022 was $18.01.

Footnote F6

A fractional share in the amount of 0.01 was issued as part of DSUs (granted in lieu of a 2007 deferred cash retainer) & DE shares earned. An additional fractional share in the amount of 0.54 was issued as part of DSUs (granted in lieu of a 2013 deferred cash retainer) & DE shares earned. The fractional shares were surrendered as non-transferrable to a registered account.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .